• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿低级别胶质瘤肿瘤大小变化的容积评估:可行性及与线性测量的比较。

Volumetric assessment of tumor size changes in pediatric low-grade gliomas: feasibility and comparison with linear measurements.

机构信息

Pediatric Neuroradiology, Department of Diagnostic Imaging, The Hospital for Sick Children, Toronto, Canada.

Department of Pediatric Neuroradiology, Department of Radiology, Great Ormond Street Hospital NHS Trust, London, WC1N 3JH, UK.

出版信息

Neuroradiology. 2018 Apr;60(4):427-436. doi: 10.1007/s00234-018-1979-3. Epub 2018 Jan 30.

DOI:10.1007/s00234-018-1979-3
PMID:29383433
Abstract

PURPOSE

We report a retrospective comparison between bi-dimensional RANO criteria and manual volumetric segmentation (MVS) in pediatric low-grade gliomas.

METHODS

MRI FLAIR or T1 post contrast images were used for assessment of tumor response. Seventy patients were included in this single center study, for each patient two scans were assessed ("time 0" and "end of therapy") and response to therapy was evaluated for both methods. Inter-reader variability and average time for volumetric assessment were also calculated.

RESULTS

Fourteen (20%) of the 70 patients had discordant results in terms of response assessment between the bi-dimensional measurements and MVS. All volumetric response assessments were in keeping with the subjective analysis of tumor (radiology report). Of the 14 patients, 6 had stable disease (SD) on MVS and progressive disease (PD) on 2D assessment, 5 patients had SD on MVS and partial response (PR) on 2D assessment, 2 patients had PD on MVS and SD on 2D assessment, and 1 patient had PR on MVS and SD on 2D analysis. The number of discordant results rises to 21(30%) if minor response is integrated in the response assessment. MVS was relatively fast and showed high inter-reader concordance.

CONCLUSION

Our analysis shows that therapeutic response classification may change in a significant number of children by performing a volumetric tumor assessment. Furthermore, MVS is not particularly time consuming and has very good inter-reader concordance.

摘要

目的

我们报告了二维 RANO 标准与小儿低级别胶质瘤的手动容积分割(MVS)之间的回顾性比较。

方法

使用 MRI FLAIR 或 T1 增强后图像评估肿瘤反应。这项单中心研究共纳入 70 例患者,每位患者评估两次扫描(“时间 0”和“治疗结束”),并使用两种方法评估治疗反应。还计算了读者间的变异性和体积评估的平均时间。

结果

在二维测量和 MVS 之间,70 例患者中有 14 例(20%)的反应评估结果存在差异。所有体积反应评估均与肿瘤的主观分析(放射学报告)一致。在 14 例患者中,6 例在 MVS 上为稳定疾病(SD),而在 2D 评估中为进展性疾病(PD),5 例在 MVS 上为 SD,而在 2D 评估中为部分反应(PR),2 例在 MVS 上为 PD,而在 2D 评估中为 SD,1 例在 MVS 上为 PR,而在 2D 分析中为 SD。如果将轻微反应纳入反应评估,则存在差异的结果数量增加到 21 例(30%)。MVS 相对较快,具有较高的读者间一致性。

结论

我们的分析表明,通过进行肿瘤体积评估,可能会在相当数量的儿童中改变治疗反应的分类。此外,MVS 并不特别耗时,并且具有非常好的读者间一致性。

相似文献

1
Volumetric assessment of tumor size changes in pediatric low-grade gliomas: feasibility and comparison with linear measurements.小儿低级别胶质瘤肿瘤大小变化的容积评估:可行性及与线性测量的比较。
Neuroradiology. 2018 Apr;60(4):427-436. doi: 10.1007/s00234-018-1979-3. Epub 2018 Jan 30.
2
Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas.评估成人高级别胶质瘤肿瘤反应中线性和体积标准的比较
Neuro Oncol. 2006 Jan;8(1):38-46. doi: 10.1215/S1522851705000529.
3
The Value of Intraoperative and Early Postoperative Magnetic Resonance Imaging in Low-Grade Glioma Surgery: A Retrospective Study.术中及术后早期磁共振成像在低级别胶质瘤手术中的价值:一项回顾性研究
World Neurosurg. 2016 Sep;93:191-7. doi: 10.1016/j.wneu.2016.04.120. Epub 2016 Jun 8.
4
Volumetric glioma quantification: comparison of manual and semi-automatic tumor segmentation for the quantification of tumor growth.体积性胶质瘤定量分析:手动与半自动肿瘤分割用于肿瘤生长定量分析的比较
Acta Radiol. 2015 Nov;56(11):1396-403. doi: 10.1177/0284185114554822. Epub 2014 Oct 22.
5
Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib.在评估非强化弥漫性神经胶质瘤中突变 IDH 抑制时,体积测量是首选的:ivosidenib 一期临床试验的证据。
Neuro Oncol. 2022 May 4;24(5):770-778. doi: 10.1093/neuonc/noab256.
6
Monitoring optic chiasmatic-hypothalamic glioma volumetric changes by MRI in children under clinical surveillance or chemotherapy.通过磁共振成像监测临床监测或化疗下儿童视交叉 - 下丘脑胶质瘤的体积变化。
Childs Nerv Syst. 2019 Jan;35(1):63-72. doi: 10.1007/s00381-018-3904-9. Epub 2018 Aug 4.
7
Tumor volumetric measurements in surgically inaccessible pediatric low-grade glioma.
J Pediatr Hematol Oncol. 2015 Jan;37(1):e31-6. doi: 10.1097/MPH.0000000000000168.
8
Low-grade gliomas in children: tumor volume response to radiation.儿童低级别胶质瘤:肿瘤体积对放疗的反应
J Neurosurg. 1998 Jun;88(6):969-74. doi: 10.3171/jns.1998.88.6.0969.
9
Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.儿童神经肿瘤学中的疗效评估:在新诊断的高级别胶质瘤儿科患者的随机II期试验中实施和扩展RANO标准
AJNR Am J Neuroradiol. 2016 Sep;37(9):1581-7. doi: 10.3174/ajnr.A4782. Epub 2016 Apr 28.
10
Diagnosing growth in low-grade gliomas with and without longitudinal volume measurements: A retrospective observational study.低级别胶质瘤的纵向体积测量与诊断:一项回顾性观察研究。
PLoS Med. 2019 May 28;16(5):e1002810. doi: 10.1371/journal.pmed.1002810. eCollection 2019 May.

引用本文的文献

1
RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice. RANO 2.0 标准:适用于神经放射学家临床实践的概念。
Curr Opin Oncol. 2024 Nov 1;36(6):536-544. doi: 10.1097/CCO.0000000000001077. Epub 2024 Jul 23.
2
The relationship between imaging features, therapeutic response, and overall survival in pediatric diffuse intrinsic pontine glioma.小儿弥漫性内在脑桥胶质瘤的影像学特征、治疗反应与总体生存的关系。
Neurosurg Rev. 2024 May 10;47(1):212. doi: 10.1007/s10143-024-02435-8.
3
Comparison of Volumetric and 2D Measurements and Longitudinal Trajectories in the Response Assessment of V600E-Mutant Pediatric Gliomas in the Pacific Pediatric Neuro-Oncology Consortium Clinical Trial.

本文引用的文献

1
Intra-rater variability in low-grade glioma segmentation.低级别胶质瘤分割中的评分者内变异性。
J Neurooncol. 2017 Jan;131(2):393-402. doi: 10.1007/s11060-016-2312-9. Epub 2016 Nov 11.
2
Fully Automated Enhanced Tumor Compartmentalization: Man vs. Machine Reloaded.全自动增强肿瘤分区:人机对决再启
PLoS One. 2016 Nov 2;11(11):e0165302. doi: 10.1371/journal.pone.0165302. eCollection 2016.
3
Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study.
在太平洋儿科神经肿瘤学联盟临床试验中,V600E 突变型小儿脑肿瘤反应评估中容积和 2D 测量及纵向轨迹的比较。
AJNR Am J Neuroradiol. 2024 Apr 8;45(4):475-482. doi: 10.3174/ajnr.A8189.
4
Basics for Pediatric Brain Tumor Imaging: Techniques and Protocol Recommendations.小儿脑肿瘤成像基础:技术与方案建议
Brain Tumor Res Treat. 2024 Jan;12(1):1-13. doi: 10.14791/btrt.2023.0037.
5
Comparison of volumetric and 2D-based response methods in the PNOC-001 pediatric low-grade glioma clinical trial.PNOC-001小儿低级别胶质瘤临床试验中容积法与基于二维的反应评估方法的比较
Neurooncol Adv. 2023 Dec 27;6(1):vdad172. doi: 10.1093/noajnl/vdad172. eCollection 2024 Jan-Dec.
6
Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integration.用于临床试验的标准化脑肿瘤成像方案:当前建议及整合要点
Front Radiol. 2023 Dec 13;3:1267615. doi: 10.3389/fradi.2023.1267615. eCollection 2023.
7
Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.依维莫司治疗复发性或进行性低度恶性脑胶质瘤患儿:来自 II 期 PNOC001 试验的结果。
J Clin Oncol. 2024 Feb 1;42(4):441-451. doi: 10.1200/JCO.23.01838. Epub 2023 Nov 17.
8
Evolution and implementation of radiographic response criteria in neuro-oncology.神经肿瘤学中影像学反应标准的演变与实施
Neurooncol Adv. 2023 Sep 13;5(1):vdad118. doi: 10.1093/noajnl/vdad118. eCollection 2023 Jan-Dec.
9
Intraoperative MRI Assessment of the Tissue Damage during Laser Ablation of Hypothalamic Hamartoma.下丘脑错构瘤激光消融术中组织损伤的术中磁共振成像评估
Diagnostics (Basel). 2023 Jul 10;13(14):2331. doi: 10.3390/diagnostics13142331.
10
Evaluation of RANO Criteria for the Assessment of Tumor Progression for Lower-Grade Gliomas.低级别胶质瘤肿瘤进展评估的RANO标准评价
Cancers (Basel). 2023 Jun 21;15(13):3274. doi: 10.3390/cancers15133274.
Ⅱ期每周长春新碱化疗方案治疗初治进展性低级别脑胶质瘤患儿:加拿大儿科脑肿瘤联盟研究。
J Clin Oncol. 2016 Oct 10;34(29):3537-3543. doi: 10.1200/JCO.2016.68.1585.
4
Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.儿童神经肿瘤学中的疗效评估:在新诊断的高级别胶质瘤儿科患者的随机II期试验中实施和扩展RANO标准
AJNR Am J Neuroradiol. 2016 Sep;37(9):1581-7. doi: 10.3174/ajnr.A4782. Epub 2016 Apr 28.
5
Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma.未经治疗的术前人类胶质母细胞瘤的对比增强肿瘤生长动力学
Cancer. 2016 Jun 1;122(11):1718-27. doi: 10.1002/cncr.29957. Epub 2016 Mar 21.
6
Semi-automated segmentation of pre-operative low grade gliomas in magnetic resonance imaging.磁共振成像中术前低级别胶质瘤的半自动分割
Cancer Imaging. 2015 Aug 14;15(1):12. doi: 10.1186/s40644-015-0047-z.
7
BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.BRAF突变和CDKN2A缺失定义了儿童继发性高级别胶质瘤一个临床上独特的亚组。
J Clin Oncol. 2015 Mar 20;33(9):1015-22. doi: 10.1200/JCO.2014.58.3922. Epub 2015 Feb 9.
8
Why measure tumours?为什么要测量肿瘤?
Pediatr Radiol. 2015 Jan;45(1):35-41. doi: 10.1007/s00247-014-3148-0. Epub 2015 Jan 1.
9
Tumor volumetric measurements in surgically inaccessible pediatric low-grade glioma.
J Pediatr Hematol Oncol. 2015 Jan;37(1):e31-6. doi: 10.1097/MPH.0000000000000168.
10
A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma.一种用于增强型胶质母细胞瘤容积磁共振成像评估的新颖、可重复且客观的方法。
J Neurosurg. 2014 Sep;121(3):536-42. doi: 10.3171/2014.4.JNS121952. Epub 2014 Jul 18.